Learn more about the potential mechanism of action of Acthar here.
*While the exact mechanism of action of Acthar is unknown, further investigation is being conducted. This information is based on nonclinical data and the relationship to clinical benefit is unknown.
In addition to its ophthalmic disease indication, Acthar is also an FDA-approved treatment option for a range of other conditions. Acthar is currently being used by rheumatologists, pulmonologists, neurologists, and nephrologists to treat inflammatory conditions across a range of approved indications.
Acthar is indicated for severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: keratitis, iritis, iridocyclitis, diffuse posterior uveitis and choroiditis, optic neuritis, chorioretinitis, anterior segment inflammation.
Dennis shares his experience with Acthar patient support services. WATCH NOW
Review how Acthar may impact various immune cells. Go
ActharOphthalmology.com is owned by Mallinckrodt. Mallinckrodt is only responsible for the content on this website.
1. Injecting Acthar: Introduction
2. Getting Started With Acthar01:57
3. Preparing the Dose Ordered for You
4. Preparing to Inject
5. Drawing Up Acthar Into the Syringe
6. Choosing Where to Inject
7. Injecting Subcutaneously
8. Disposing of Used Materials
9. Storing Acthar
10. Patient Support Services
11. Important Safety Information
2. Getting Started With Acthar
3. Preparing the Dose Ordered for You0:59
4. Preparing to Inject00:49
7. Injecting Intramuscularly
Potential Mechanism of Action Video
Hear From Dennis: An Acthar Patient
SC Injection Training Video
IM Injection Training Video